サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1513862

HIV/エイズ検査の世界市場

HIV/AIDS Testing

出版日
ページ情報
英文 202 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
HIV/エイズ検査の世界市場
出版日: 2024年07月17日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 202 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

HIV/エイズ検査の世界市場は2030年までに58億米ドルに達する見込み

2023年に38億米ドルと推定されるHIV/エイズ検査の世界市場は、2023年から2030年にかけてCAGR 6.1%で成長し、2030年には58億米ドルに達すると予測されます。HIV/エイズ検査器械は、本レポートで分析したセグメントの1つであり、CAGRは5.5%を記録し、分析期間終了時には36億米ドルに達すると予測されています。HIV/エイズ検査キット＆試薬セグメントの成長率は、分析期間中CAGR 7.1％と推定されます。

米国市場は推定10億米ドル、中国はCAGR 9.9％で成長予測

米国のHIV/エイズ検査市場は2023年に10億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに13億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは9.9%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.2%と6.4%と予測されています。欧州では、ドイツがCAGR 3.4%で成長すると予測されています。

HIV/エイズ検査：主要動向と促進要因

HIV/エイズ検査の状況は、世界の健康への取り組み、技術の向上、早期発見の重要性に対する意識の高まりによって大きく前進しています。世界保健機関（WHO）や国連合同エイズ計画（UNAIDS）などの国際機関のイニシアチブは、HIV/エイズの蔓延を終わらせることを目的としており、HIV検査サービスの拡大を大きく後押ししています。多くの国では、ハイリスク集団や一般市民に対して定期的なHIV検査を義務付け、または奨励する国家政策を実施しており、多くの場合、無料または助成金付きの検査を提供する政府の支援によるスクリーニング・プログラムによって支えられています。このような取り組みは、一般市民を対象とした教育キャンペーンとともに、HIV検査の普及率と頻度を高め、HIVという病気を非人格化し、より多くの人々が検査を受けるよう促しています。

HIV検査における技術の進歩は、こうした診断法の利用しやすさ、正確さ、利便性を急速に高めています。ポイントオブケア検査、自己検査キット、次世代シーケンシング（NGS）やCRISPRベースの診断のような革新的な診断プラットフォームなどの最新技術は、HIV診断に変革をもたらしつつあります。これらの技術は、曝露後の早期発見を可能にするだけでなく、従来のヘルスケア環境を超えて検査を拡大し、より広範な人々に検査を提供します。さらに、人工知能の統合は、診断プロセスを合理化し、早期発見を強化し、治療戦略を個別化し、患者の転帰を改善するために極めて重要です。

自己検査キットと移動医療ユニットの台頭は、HIV検査へのアクセシビリティを高める上で特に注目に値します。自己検査キットは、HIVにまつわるスティグマが大きい地域では魅力的な、個人的で便利な選択肢を提供し、そうでなければ従来の環境を避けるかもしれない人々の検査率を高める。移動診療ユニットは、遠隔地や十分な診療を受けていない地域にもHIV検査の範囲を広げ、必要不可欠な診断サービスへのアクセスをさらに拡大します。さらに、検査前・検査後のカウンセリング、結果の追跡、管理のための遠隔医療とデジタル・プラットフォームの統合は、検査プロセスの効率性と機密性を高める。このような技術革新とサービス提供の革新は、HIV/AIDSの管理と予防に関する公衆衛生の状況を改善し、HIV/AIDS蔓延に対する世界の闘いを推進し続けると思われます。

調査対象企業の例（全12件）

  • Abbott Molecular, Inc.
  • Abbott Molecular, Inc.
  • Bio-Rad Laboratories, Inc.
  • Chembio Diagnostic Systems, Inc.
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • OraSure Technologies, Inc.
  • Siemens Healthineers

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP-3401

Global HIV/AIDS Testing Market to Reach US$5.8 Billion by 2030

The global market for HIV/AIDS Testing estimated at US$3.8 Billion in the year 2023, is expected to reach US$5.8 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. HIV/AIDS Testing Instruments, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$3.6 Billion by the end of the analysis period. Growth in the HIV/AIDS Testing Kits & Reagents segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.0 Billion While China is Forecast to Grow at 9.9% CAGR

The HIV/AIDS Testing market in the U.S. is estimated at US$1.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 9.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

HIV/AIDS Testing  - Key Trends and Drivers

The landscape of HIV/AIDS testing has seen significant advancements driven by global health initiatives, technological improvements, and heightened awareness of the importance of early detection. Initiatives from international organizations such as the World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS) aim to end the HIV/AIDS epidemic and have significantly driven the expansion of HIV testing services. Many countries have implemented national policies that mandate or encourage regular HIV testing in high-risk populations and the general public, supported by government-backed screening programs that often offer free or subsidized testing. These efforts, along with public education campaigns, have increased testing coverage and frequency, helping to destigmatize the disease and encourage more people to seek testing.

Technological advancements in HIV testing are rapidly enhancing the accessibility, accuracy, and convenience of these diagnostic methods. Modern technologies such as point-of-care tests, self-testing kits, and innovative diagnostic platforms like Next-Generation Sequencing (NGS) and CRISPR-based diagnostics are transforming HIV diagnostics. These technologies not only allow for earlier detection following exposure but also expand testing beyond traditional healthcare settings, reaching broader populations. Furthermore, the integration of artificial intelligence is streamlining the diagnostic process, enhancing early detection, and personalizing treatment strategies, which are crucial for improving patient outcomes.

The rise of self-testing kits and mobile health units is particularly notable in increasing accessibility to HIV testing. Self-testing kits offer a private, convenient option that is appealing in regions where there is significant stigma associated with HIV, increasing testing rates among populations that might otherwise avoid traditional settings. Mobile health units extend the reach of HIV testing into remote or underserved areas, further expanding access to essential diagnostic services. Additionally, the integration of telehealth and digital platforms for pre-test and post-test counseling, result tracking, and management enhances the efficiency and confidentiality of the testing process. These technological and service delivery innovations are set to continue driving the global fight against the HIV/AIDS epidemic, improving the landscape of public health with regards to HIV/AIDS management and prevention.

Select Competitors (Total 12 Featured) -

  • Abbott Molecular, Inc.
  • Abbott Molecular, Inc.
  • Bio-Rad Laboratories, Inc.
  • Chembio Diagnostic Systems, Inc.
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • OraSure Technologies, Inc.
  • Siemens Healthineers

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • HIV/AIDS Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of HIV Infections Globally Strengthens Business Case for Comprehensive Testing Solutions
    • Advances in Diagnostic Technologies Propel Growth of HIV/AIDS Testing Market
    • Increasing Adoption of Home Testing Kits Expands Addressable Market Opportunity for HIV/AIDS Testing
    • Growth in Awareness and Preventive Healthcare Measures Generates Demand for Regular HIV Testing
    • Innovations in Rapid and Point-of-Care Testing Devices Spurs Market Growth for HIV/AIDS Testing
    • Stringent Regulatory Requirements for Diagnostic Accuracy Drives Adoption of High-Precision HIV Tests
    • Focus on Early Detection and Intervention Throws the Spotlight on Advanced HIV Testing Solutions
    • Integration of AI and Machine Learning in Diagnostics Enhances HIV Test Accuracy
    • Rising Investment in Healthcare Infrastructure Generates Opportunities for Innovation in HIV/AIDS Testing
    • Technological Developments in Portable and Wearable Testing Devices Propel Market Expansion for HIV/AIDS Testing
    • Emphasis on Reducing Stigma and Increasing Access Drives Adoption of User-Friendly HIV Testing Solutions
    • Adoption of HIV Testing in Routine Health Check-Ups Expands Addressable Market Opportunity
    • Increasing Use of HIV Testing in High-Risk Populations Accelerates Demand for Comprehensive Screening Solutions
    • Government Initiatives and Funding for HIV/AIDS Research and Prevention Strengthens Business Case for Testing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for HIV/AIDS Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Diagnostics Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Diagnostics Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Diagnostics Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World HIV/AIDS Testing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • HIV/AIDS Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • HIV/AIDS Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • HIV/AIDS Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • HIV/AIDS Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for HIV/AIDS Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • HIV/AIDS Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • HIV/AIDS Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • HIV/AIDS Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • HIV/AIDS Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for HIV/AIDS Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • HIV/AIDS Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • HIV/AIDS Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • HIV/AIDS Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for HIV/AIDS Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • HIV/AIDS Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for HIV/AIDS Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • HIV/AIDS Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product - Instruments and Kits & Reagents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for HIV/AIDS Testing by Product - Instruments and Kits & Reagents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for HIV/AIDS Testing by Product - Percentage Breakdown of Value Sales for Instruments and Kits & Reagents for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for HIV/AIDS Testing by End-Use - Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for HIV/AIDS Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostics Laboratories, Hospitals, Research Institutes and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION